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CD148 Is a Membrane Protein Tyrosine Phosphatase Present in All Hematopoietic
Lineages and Is Involved in Signal Transduction on Lymphocytes
By Miguel Angel de la Fuente-Garcı´a, Josep Maria Nicola´s, John H. Freed, Eduard Palou, Andrew P. Thomas,
Ramo´n Vilella, Jordi Vives, and Antoni Gaya´
Evidence is presented showing that a protein tyrosine phos-
phatase different from CD45 is present on the membrane of
human hematopoietic cells. The molecule recognized by the
monoclonal antibody 143-41, which has been classified as
CD148 in the VI International Workshop on Leukocyte Differ-
entiation Antigens, was immunopurified and sequenced.
The sequence obtained from N-terminus as well as from two
different CNBr-digested peptides showed a close identity
with a previously described tyrosine phosphatase named
HPTP-h/DEP-1. CD148 is present on all hematopoietic lin-
eages, being expressed with higher intensity on granulo-
cytes than on monocytes and lymphocytes. Interestingly,
whereas it is clearly present on peripheral blood lympho-
cytes, it is poorly expressed on different lymphoid cell lines
of T and B origin. When this protein tyrosine phosphatase
was cocrosslinked with CD3, an inhibition of the normally
observed calcium mobilization was observed. This inhibition
correlates with a decrease in phospholipase C-g (PLC-g)
phosphorylation and is similar to the one observed with
CD45. In addition, it is shown that the crosslinking of the
CD148 alone is also able to induce an increase in [Ca21]i. This
increase is abolished in the presence of genistein and by
cocrosslinking with CD45. These data, together with the
induction of tyrosine phosphorylation on several substrates,
including PLC-g, after CD148 crosslinking, suggest the in-
volvement of a tyrosine kinase-based signaling pathway in
this process. In conclusion, the data presented show that
CD148 corresponds to a previously described protein tyro-
sine phosphatase HPTP-h/DEP-1 and that this molecule is
involved in signal transduction in lymphocytes.
r 1998 by The American Society of Hematology.
THE PHOSPHORYLATION of tyrosine residues of proteinsis a crucial event in the regulation of cellular processes,
including those of proliferation and differentiation. The level of
protein phosphorylation is mainly the result of the antagonistic
functions of protein-tyrosine kinases (PTKs) and protein-
tyrosine phosphatases (PTPs).1,2 Thus, the activation and inacti-
vation of both enzymes are relevant in determining the func-
tional state of a great variety of intracellular molecules.
In recent years an increasing number of PTPs have been
described. Currently over 40 PTPs have been reported.3 They
have been subcategorized4 into three groups: (1) receptor-like
PTPs, (2) intracellular PTPs, and (3) dual specific PTPs. The
common structural features of the receptor-like PTPs include an
extracellular domain of variable length and composition, a
single membrane-spanning region, and one or two intracellular
catalytic domains.
The interaction of T cell receptor (TCR) with the appropriate
antigen or its stimulation with antireceptor antibodies induces a
signal transduction cascade that leads to the expression of a
number of genes and eventually to effector functions. One of the
earliest biological events after lymphocyte stimulation is the
activation of PTKs, which results in tyrosine phosphorylation of
various cellular proteins. Recently it has been observed that the
rapid, and generally transient, tyrosine phosphorylation re-
sponse is the result of a complex and still poorly understood
kinase cascade involving at least three families of PTKs: src,
syk, and csk (see Zenner et al5 for review). Although leukocytes
express a wide variety of PTPs in the cytoplasm, their precise
role remains unknown in most of the cases.6 Among the PTPs,
CD45 is the only membrane PTP that has been described to be
involved in the process of signal transduction,7 modulating the
response to antigen receptor engagement in both T8 and B
lymphocytes.9
In this report we present evidence that the recently described
CD14810 corresponds to a previously described membrane PTP,
HPTPh/DEP-1.11-13 This molecule is present on all hematopoi-
etic lineages and, in addition to being able to transduce signals
by itself, it is also able to modulate the signal transduction
through the TCR/CD3 complex in a manner similar to CD45.
MATERIALS AND METHODS
Cells. Blood samples were obtained from healthy adult donors.
Peripheral blood mononuclear cells (PBMCs) were isolated by centrifu-
gation over Ficoll-Hypaque (Pharmacia LKB, Uppsala, Sweden) density-
gradient sedimentation. The following cell lines were grown in RPMI
plus 10% fetal calf serum (FCS): CEM, HPB-ALL, HSB2, JURKAT,
MOLT-4, RAJI, KM3, NAMALWA, RAMOS, NALM-6, K562, U937,
and HL-60.
Monoclonal antibodies (MoAbs). The following MoAbs were pro-
duced in our laboratory and ascribed to their CDs through one of the
International Workshop on Human Leukocyte Differentiation Antigens
(WLDA): CRIS-7 (CD3, IgG2a), 72-5D3 (CD45, IgG2a), and 111-5A1
(CD41, IgG1). MoAbs were purified from ascitic fluid by protein A
affinity chromatography. The 143-41 (IgG1) hybridoma was produced
in accordance with a previously described method14 after immunization
of BALB/c mice with PBMCs that had previously been stimulated with
phytohemagglutinin (PHA) for 3 days. The following phycoerythrin
(PE)-labeled MoAbs were used: HD-37 (CD19), Leu 4 (CD3), and
mouse IgG2a control (Becton Dickinson, San Jose, CA).
Immunofluorescence assay. The 143-41 MoAb was labeled with
fluorescein following conventional techniques. Cells were washed with
immunofluorescence buffer (phosphate-buffered saline [PBS] contain-
ing 0.02 mmol/L sodium azide and 1% bovine serum albumin [BSA])
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and incubated with specific MoAb or isotype-matched control MoAb
for 30 minutes on ice in immunofluorescence (IF) buffer containing 5%
rabbit serum. For two-color analysis the simultaneous combination of
143-41 fluorescein isothiocyanate (FITC)-conjugated MoAb with a
PE-conjugated MoAb, was used. Samples were run on a FACScan flow
cytometer (Becton Dickinson). Where applicable, different cell popula-
tions (eg, lymphocytes, monocytes, and neutrophils) were identified
based on 2-dimensional light scatter characteristics.
Surface biotinylation, immunoprecipitation, specific glycosidases
treatment, and immunoblotting. Adult human peripheral blood mono-
nuclear cells were isolated from healthy donors by centrifugation over
Ficoll-Hypaque. Cells were prepared for surface biotinylation by
washing twice in PBS and resuspending at 5 3 107 cells/mL in PBS
containing 200 µg/mL Sulfo-NHS-Biotin (Pierce, Rockford, IL). Label-
ing was allowed to proceed for 30 minutes at 4°C and was quenched by
incubation for 15 minutes at room temperature with an equal volume of
RPMI 1640 medium supplemented with 10% FCS. Cells were then
washed three times in cold PBS and lysed. After 20 minutes on ice,
postnuclear extracts were added to CNBr-activated Sepharose 4B
(Pharmacia LKB) that had been previously coupled to 143-41 antibody
and blocked with 2% BSA (Sigma Chemical Co, St Louis, MO). After
60 minutes at 4°C, immunoprecipitates were washed five times in lysis
buffer (0.5% Nonidet P-40, 10 mmol/L Tris-HCL, pH 7.40, 150 mmol/L
NaCl, 1 mmol/L EDTA, 1 mmol/L EGTA, 1 mmol/L NaF, 20 mg/mL
egg white trypsin inhibitor, 1 mg/mL leupeptin, 1 mg/mL pepstatin, 1
IU/mL aprotinin, and 1 mmol/L phenylmethyl sulfonyl fluoride [PMSF])
containing 0.05% sodium dodecyl sulfate (SDS). For deglycosylation,
samples of immunoprecipitates were washed and, after boiling, resus-
pended in the corresponding buffers prepared according to manufactur-
er’s instructions for Neuraminidase (150 mU/50 mL; Boehringer-
Mannheim, Mannheim, Germany), O-Glycosidase (1.5 mU/50 mL,
Boehringer-Mannheim) and recombinant N-glycosidase F (0.7 mU/100
mL, Boehringer-Mannheim). Overnight digestions at 37°C were usually
used; however, for Neuraminidase treatment a shorter digestion time (2
hours) was used. The glycosidase-treated proteins were run on 5%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred to Immobilon-P (Millipore Corp, Bedford, MA)
in 39 mmol/L glycine, 48 mmol/L Tris-base, 1.3 mmol/L SDS, and 5%
methanol for 2 hours at 60 V. After incubating the filters with blocking
solution (10% nonfat milk protein in PBS) for 2 hours at 4°C, blots were
incubated with streptavidin-peroxidase (Sigma Chemical Co) at 1:2,000
in blocking solution for 1 hour at 20°C. Filters were washed again with
0.1% Tween-20 in PBS, and the Western blots were developed using
substrate solution (0.6 mg/mL diaminobenzidine, 0.1% hydrogen
peroxide (30%), and 0.3% (wt/vol) CoCl2).
Immunoaffınity purification and protein sequencing. The molecule
recognized by 143-41 MoAb was purified following previously de-
scribed procedures15 with modifications. Buffy coats from normal
healthy donors were obtained and erythrocytes separated by sedimenta-
tion in PBS-2% Dextran-500 (Pharmacia LKB). Leukocyte-rich super-
natants were centrifuged, and about 20 3 109 white blood cells were
obtained and washed twice in PBS. Pellets were disrupted in lysis buffer
for 30 minutes on ice. Insoluble material was removed by centrifugation
at 50,000g for 30 minutes at 4°C and the supernatant was precleared by
passing it sequentially through columns of CNBr-activated Sepha-
rose-4B beads alone and CNBr-activated Sepharose 4B beads coupled
with polyclonal mouse Ig or irrelevant IgG1 MoAb. The resulting lysate
was then applied to a column of CNBr-activated Sepharose 4B beads
(15 mL) derivatized with MoAb 143.41. The affinity column was
washed extensively with modified lysis buffer containing 0.05% NP40
and then with two column volumes of PBS 0.5 mol/L MgCl2. The bound
material was eluted with 4 mol/L MgCl2 in PBS and the sample
concentrated to 150 µL using a Centriprep 30 membrane (AMICON,
Beverly, MA) while the buffer was changed to PBS. Cyanogen bromide
cleavage of the protein was performed according to a previously
described protocol15: 400 mg of protein were resolved with SDS-PAGE
(5%) and electroblotted onto nitrocellulose membrane. After transfer, a
band visualized by Ponceau S (Sigma Chemical Co), was excised,
transferred to a screwcap microvial, and incubated in 300 µL of 0.150
mol/L CNBr (Pierce Chemical Co) in 70% formic acid (vol/vol) (E.
Merck, Damstadt, Germany) for 4 hours in the dark, at room tempera-
ture. After cleavage, membrane fragment was dried completely with N2
and washed with 200 µL water and dried again. The protein fragments
were redissolved in Laemmli’s sample buffer containing 5% mercapto-
ethanol, and the SDS-PAGE for the separation of the peptides was 20%
acrylamide (200:1, acrylamyde:bis), 10% (vol/vol) glycerol, 0.75 mol/L
Tris pH 9.3, and 0.1% SDS. The gel was aged 2 days, and the running
buffer contained 0.1 mmol/L thioglycolate. After the run, the proteins
were blotted onto polyvinylidine difluoride membrane (ProBlott; Ap-
plied Biosystems, Inc, Foster City, CA) with transfer buffer (48 mmol/L
Tris pH 9, 39 mmol/L Tricine, 1.3 mmol/L SDS, and 20% methanol).
SDS-PAGE molecular weight standards (Bio-Rad Laboratories, Rich-
mond, CA) were used. The membrane was stained with AmidoBlack
(0.1% in 40% methanol, 1% acetic acid), washed thoroughly in H2O,
and dried. Two bands were cut out and stored in microvials filled with
N2. NH2-terminal sequence analysis of the intact protein and the two
protein fragments was performed on an Applied Biosystems 470A/
120A microsequencer.
Phosphatase assay. Substrate preparation and PTP assay were
performed with the Malachite Green Phosphatase Assay (Upstate
Biotechnology Inc, Lake Placid, NY) as described in the product
manual. Affinity purified 143-41 and CD50 molecules (kindly provided
by Dr C. Vilardell, H. Clinic, Barcelona, Spain) were diluted in assay
buffer (10 mmol/L Tris-HCl, pH 7.4) and added to microtiter wells with or
without the substrate phosphopeptide (2 mmol/L, TSTEPQpYQPGENL)
allowing enzyme reaction to proceed for 30 minutes. One hundred
microliters per well Malachite Green solution was added, and after
incubation for 15 minutes the absorbance at 620 nm was determined
with a Titertek Multiscan enzyme-linked immunosorbent assay reader
(Flow Laboratories, Rockville, MD). The assay was performed in the
presence or absence of 10-mmol/L sodium orthovanadate (Sigma
Chemical Co).
Transfection of COS cells. A full-length cDNA (hp21) encoding the
human protein-tyrosine phosphatase h (HPTP-h)12 was the kind gift of
Drs H. Honda and H. Hirai, Faculty of Medicine, University of Tokyo,
Japan. To examine whether MoAb 143-41 recognizes HPTP-h gene
product, COS-7 cells were transfected by lipofection. Briefly, 1 3 106
cells in log phase were washed twice with PBS and incubated in
serum-free Dulbecco’s modified Eagle’s medium containing 30 µg/mL
DOTAP (N-[1-(2,3-Dioleoyloxy)propyl]-N,n,n-trimethylammonium
methylsulfate; Boehringer Mannheim GmbH, Mannheim, Germany)
and 5 µg of the pSSRa expression vector with hp21 insert, or 5 µg of the
pSSRa plasmid alone (mock transfection) at 37°C for 6 hours. After 2
days, cells were stained with 143-41 MoAb and FITC-labeled goat
antimouse Ig and analyzed on a FACScan flow cytometer (Becton
Dickinson).
Analysis of [Ca21]i. [Ca21]i was measured in individual lympho-
cytes basically following the method described by Wacholtz and
Lipsky.16 Briefly, peripheral blood lymphocytes (PBL) were resus-
pended at a final concentration of 30 3 106 cells/mL in RPMI
supplemented with 10% FCS. Cells were loaded with fura-2 acetoxy-
methyl ester (fura-2/AM; 2 mmol/L; Calbiochem, San Diego, CA) by
incubation for 25 minutes at 37°C, with gentle shaking. After fura-2
loading, lymphocytes were incubated with MoAbs (CRIS-7: 10 mg/mL
and 72-5D3, 143-41,111-5A1: 40 mg/mL) for 30 minutes at 4°C. After
washing, fura-2-loaded PBL (106 cells) were plated on the center of a
25-mm glass coverslip coated with Cell-Tak (Collaborative Biomedical
Products, Bedford, MA) in 50 mL of RPMI medium without FCS. The
cells were incubated for 20 minutes at 37°C under an atmosphere of 5%
CO2/air, and washed with incubation buffer composed of 121 mmol/L
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NaCl, 10 mmol/L HEPES, 5 mmol/L NaHCO3, 4.7 mmol/L KCl, 1.2
mmol/L KH2PO4, 1.2 mmol/L MgSO4, 2 mmol/L CaCl2, 10 mmol/L
glucose, and 0.01% BSA at pH 7.4 to remove unattached and nonviable
cells. Coverslips with attached lymphocytes were transferred into an
open flow chamber (1 mL, volume) mounted on the heated stage of a
Nikon Diaphot-300 inverted epifluorescence microscope. The stage, 40
3 fluor immersion objective (Nikon) and chamber were maintained at
37°C. Ca21 mobilization was induced by the crosslinking of cell surface
molecules after addition of a second step saturating amount of
polyclonal affinity purified goat-antimouse antiserum (GAM; Tago Inc,
Burlingame, CA). Cells were considered to respond when [Ca21]i
increased more than 100% of the basal level. Fluorescence images were
obtained by a CCD CH250 camera (Photometrics, Tucson, AZ) and
were digitized, stored, and analyzed in an Apple-MacIntosh 840AV
computer (Apple Computers Inc, Cupertino, CA). Images were col-
lected alternately at excitation wavelengths of 340 and 380 nm (10 nm
bandwidth filters) to excite the Ca21-bound and Ca21-free forms of this
ratiometric dye, respectively. The emission wavelength was 510 nm
(120 nm bandwidth filter). The integration time for each image was 100
ms, and individual pixels were binned into 2 3 2 superpixels at read out
from the charge coupled device detector to improve signal to noise. To
minimize photobleaching, a computer-controlled shutter was used to
limit the exposure of the cells to excitation light. [Ca21]i values were
calculated on a single-cell basis from the 340- to 380-nm fluorescence
ratios at each time point as described previously.17,18 All images were
checked for movement artifacts, and a reference point was used to
obtain true coregistration of the 340- and 380-nm images. At the end of
each experiment, cells were exposed to ionomicyn (10 mmol/L) and
MnCl2 for 20 minutes. This treatment quenches the fluorescence of the
intracellular Ca21-sensitive fura-2, leaving the residual fluorescence at
each wavelength because of cell autofluorescence and any Ca21-
insensitive forms of the dye. The residual fluorescence was measured
over the same region of each cell as the Ca21-dependent fluorescence.
Statistics. Standard statistical methods from SPSS Statistical Analy-
sis System V4.01 (SPSS, Chicago, IL) were used. Paired two-tailed
t-tests were used to analyze the differences between conditions in each
experiment. All variables were expressed as mean 6 standard error
(SE), and a significance level of P , .05 was used.
Cell stimulation and tyrosine phosphorylation analysis. Cells (50 3
106) were incubated with the different MoAbs (10 µg) for 15 minutes at
4°C followed by the addition of crosslinking rabbit antimouse Igs (5
µg). Incubation was terminated after different periods of time by the
addition of 1 mL of ice-cold stop buffer (50 mmol/L HEPES, 150
mmol/L NaCl, 100 mmol/L NaF, 10 mmol/L EDTA, 10 mmol/L
Na4P2O7, 2 mmol/L sodium pervanadate, 2 mmol/L PMSF, 10 mg/mL
aprotinin, 10 mg/mL pepstatin, 1 mg/mL leupeptin, 100 mmol/L PAO).
Cells were pelleted and lysed with stop buffer containing 1% NP-40.
Proteins were separated by SDS-PAGE and transferred to nitrocellulose
membranes. Phosphotyrosine-containing proteins were probed with
antiphosphotyrosine MoAb PY-20 from Santa Cruz Biotechnology
(Santa Cruz, CA) and horseradish peroxidase-conjugated rabbit anti-
mouse and visualized by fluorography with enhanced chemilumines-
cence reagent (Amersham, Buckinghamshire, UK).
Immunoprecipitation of phospholipase C-g1. For immunoprecipita-
tion experiments, cell lysates of 25 3 105 stimulated cells were prepared
as described previously. Precleared lysates were incubated overnight
with 1 µg of anti–PLC-g1 MoAb (UBI Inc, Lake Placid, NY).
Immunoprecipitates were recovered by incubation with 20 µL of Protein
A-Sepharose beads for 120 minutes at 4°C and washed three times in
lysis buffer. The proteins were then eluted and dissolved by boiling for 5
minutes in Laemmli sample buffer and subsequently resolved by
SDS-PAGE. Western blot analysis was then performed using PY20
antiphosphotyrosine antibody (UBI Inc), biotinylated goat antimouse
(Sigma Chemical Co), and avidin-peroxidase (Sigma Chemical Co) as
described above. Next, membranes were stripped of primary antibody
with stripping buffer (100 mmol/L 2-ME, 2% SDS, Tris-Cl 65 mmol/L,
pH 5 7.5) washed and reprobed with anti–PLC-g1 MoAb (UBI Inc).
RESULTS
Phenotypic and immunochemical characterization of CD148.
With the aim of producing MoAbs defining new membrane
proteins, several MoAbs were obtained in our laboratory. One
of them, MoAb 143-41, defined a molecule present on periph-
eral blood cells that shows its highest expression on granulo-
cytes, being present at intermediate intensity on monocytes and
lymphocytes (Fig 1A, left). Its expression on red blood cells and
platelets was even lower than the one observed on those cells
(Fig 1A, right). This molecule was detected on both T and B
lymphocytes as determined by double immunofluorescence
with FITC-labeled 143-41 and PE-labeled CD3 and CD19 (Fig
1B). The reaction of 143-41 MoAb with different hematopoietic
cell lines was also tested (Fig 2). Thus, CD148 showed a clear
reaction with cell lines of myeloid origin (K562, U937, and
HL-60) and with some B-cell lines (Raji, KM3, Nalm-6),
whereas this was weakly expressed on Namalwa and Ramos,
also of B-cell origin. Surprisingly, and in contrast with the clear
expression observed on CD31 lymphocytes, it was not detected
Fig 1. Flow cytometric analysis of human hematopoietic cell
lineages. Whole blood was stained with fluoresceinated-CD148 as
described in Materials and Methods and analyzed on a FACScan flow
cytometer. (A) Erythrocytes and platelets were analyzed after select-
ing cell populations by side scatter and forward size. In parallel, after
washing, erythrocytes were lysed by incubating with lysis buffer and
the different leukocyte populations were selected on basis of cell
scatter and forward size characteristics. Histograms for fluorescence
of simultaneously stained lymphocytes, monocytes, and granulo-
cytes have been superimposed. (B) PBL were obtained from normal
healthy donors by Ficoll-Hypaque gradient density centrifugation and
lymphocyte populations were analyzed by two color fluorescence by
using fluoresceinated 143-41 MoAb and comercially available PE-
labeled CD3 and CD19 MoAb. The appropiate negative control FITC-
and PE-labeled MoAbs were used to establish the marker position.
The staining intensity of PE-labeled cells is shown in the vertical axis
with 143-41–FITC staining on the horizontal axis.
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on T-cell lines (CEM, HPB-ALL, Jurkat, and MOLT-4) with the
exception of HSB-2.
Although this MoAb was analyzed during the IV WLDA it
could not be clustered. During the work of the VI WLDA held
recently in Kobe, another MoAb (A3) with a similar pattern of
reaction was detected. In basis of the comparative analysis of
this antibody with our MoAb 143-41, a new cluster of
differentiation could be defined: CD148.10
To further characterize this molecule a thoroughly biochemi-
cal characterization was performed. The molecule was immuno-
precipitated, and before and after digestion with neuraminidase,
O-glycanase, and N-glycanase it was subjected to electrophore-
sis in reducing conditions and analyzed by immunoblotting, as
described in Materials and Methods. As can be observed in Fig
3, CD148 appeared before treatment as a broad band with an
apparent molecular weight of 240 kD. Treatment of purified
CD148 with the various glycosidases led to alterations in the
electrophoretic mobility of the protein. Thus, after treatment
with N-glycosidase F, the molecular weight of CD148 was
shifted to a much smaller size in Western blot analysis,
indicating that the molecule recognized by 143-41 was a
glycoprotein containing Asn-linked carbohydrate and that the
molecular weight of this molecule was, for the most part,
modified by the N-glycosylation. O-Glycanase treatment also
affected the electrophoretic mobility of the CD148 by decreas-
ing its apparent molecular weight under reducing conditions. In
addition, a slight decrease in the electrophoretic mobility was
observed after treatment with neuraminidase suggesting the
existence of sialic acid residues. The reaction of CD148 with
Maackia amurensis and Sambucus nigra L biotinylated lectins,
confirmed this presence and showed that they are linked in both
a(2-3) and a(2-6) to galactose (data not shown).
Protein sequencing and identification as HPTP-h/DEP-1.
CD148 was purified by immunoaffinity chromatography from
leukocyte membranes and subjected to N-terminal sequencing.
After digestion of CD148 with CNBr, several peptides were
obtained, two of them being subjected to N-terminal sequenc-
ing. The sequences obtained are shown in Fig 4. A complete
homology of these sequences with the recently described PTP
HPTP-h12 or DEP-113 was detected. As can be seen in Fig 4, in
all the positions in which a clear sequence was obtained, an
identity of sequence was observed. In both CNBr-derived
peptides it was observed that the sequence started after a
methionine residue in the sequence of the PTP, in agreement
Fig 2. Expression patterns of CD148 on different cell lines of
myeloid and lymphoid origin. The 143-41 MoAb was assayed for their
binding to cell lines by first incubating the cells with a saturating
amount of antibody and, after washing, cells were incubated with a
FITC-labeled goat antimouse antibody (—). Cells were also stained
with a control isotype-matched antibody. The staining intensity of
FITC-labeled cells is shown on the horizontal axis with the number of
cells on the vertical axis.
Fig 3. Immunochemical characterization of CD148 molecule. Adult
human PBMCs were surface biotinylated and CD148 molecule was
immunoprecipitated by using 143-41–coupled CNBr-activated Sepha-
rose 4B. Sample aliquots were subjected to treatment with
N-endoglycosidase F (lane 3), O-endoglycosidase (lane 2), and neur-
aminidase (lane 1) as described in the Materials and Methods. Next,
samples were analyzed on a 5% SDS-polyacrylamide gel under
reducing conditions before (lane 4) and after glycanase treatment
(lanes 1, 2, and 3), followed by electrophoretic transfer of proteins
onto Immobilon-P. After blocking and incubating with streptavidin-
peroxidase, the Western blots were developed using diaminobenzi-
dine with cobalt enhancement.
Fig 4. Identity between CD148 N terminal and peptide sequence
and deduced HPTP-h/DEP-1 protein sequence from the cDNA. Num-
bering of HPTP-h/DEP-1 amino acid positions are from Honda et al12
and O¨stman et al.13 Assignment of X in the CD148 sequence repre-
sents nonidentifiable signal in the sequence analysis.
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with the existence of a point of cleavage for CNBr. From the
N-terminal sequence data we obtained, it should be noted that
the mature N terminus corresponds to Ala 36 and not to Thr 39
(HPTP-h)12 or Gly 37 (DEP-1).13
To confirm that the molecule recognized by 143-41 MoAb
corresponds to the previously described protein tyrosine phos-
phatase HPTP-h/DEP-1 two different approaches were under-
taken. First, hp21, a full length HPTP-h cDNA was used to
transfect COS-7 cells. When stained with 143-41 MoAb,
whereas mock-transfected COS-7 cells were negative (Fig 5A),
the COS-7 cells transfected with the HPTP-h cDNA showed a
clear positive reaction (Fig 5B). In addition, the phosphatase
activity of CD148 was analyzed by testing its ability to release
phosphate groups from a tyrosine phosphorylated peptide. As
can be observed in Fig 6 a clear tyrosine phosphatase activity
was observed when immunopurified CD148 was tested. This
activity was clearly diminished in the presence of sodium
orthovanadate, a PTP inhibitor. No PTP activity was detected
when a similarly immunopurified molecule, CD50, was tested
in the same assay.
Ca21 mobilization after CD3, CD148, and CD45 crosslink-
ing. Previous studies had shown that CD3-induced Ca21
mobilization is modulated by the tyrosine phosphatase activity
of CD45 when both molecules were cocrosslinked.7 Based on
the fact that CD148 was identified as a PTP expressed on the
membrane of lymphocytes, we evaluated whether CD148 could
modify the activation induced by CD3 crosslinking. Therefore,
PBL were loaded with fura-2/AM, and Ca21 mobilization after
cell stimulation was analyzed by computer-aided fluorescence
imaging. Figure 7 depicts the mean changes of [Ca21]i including
all PBL populations after crosslinking the CD3 molecule. These
data are normalized to the basal values before the addition of
affinity purified GAM, and Ca21 changes were measured in
individual cells. Mean [Ca21]i increased from a baseline of
71 6 4 nmol/L to 163 6 15 nmol/L after addition of the CD3
crosslinking agent. In agreement with previous results,7 we
observed a significant decrease in the CD3-induced response
because of CD45 cocrosslinking. Moreover, when CD3 was
cocrosslinked with CD148, we also observed a clear reduction
in the mean peak [Ca21]i response (P , .05; n 5 5 experiments;
Fig 7), suggesting that the PTP activity of CD148 could
modulate signals transduced through the CD3 complex, simi-
larly to CD45. Interestingly enough, when CD148 alone was
crosslinked, we observed an increase in the mean [Ca21]i,
reaching a mean peak of 130 6 8 nmol/L, which was delayed
and significantly lower (P , .05, n 5 6 in both experiments; Fig
7) when compared with CD3 crosslinking stimulation. In
addition, to determine the role of tyrosine phosphorylation in
[Ca21]i increase induced by CD148 stimulation we tested
whether the phosphatase activity of CD45 could abolish this
effect when both molecules were cocrosslinked, as has been
described in other tyrosine kinase-mediated activations.19 As
can be observed in Fig 8, the [Ca21]i increase induced by
CD148 crosslinking was inhibited when CD45 was co-
crosslinked with CD148.
Because the mean [Ca21]i kinetics may be influenced either
by the percentage of responding cells, appearance of unsynchro-
nized responses, or variable intensity response,20 individual cell
measurements of the [Ca21]i changes after CD3, CD45, and
CD148 crosslinking were also evaluated (Fig 8). For the
analysis of the single cell responses, we considered a response
significant when the Ca21 mobilization induced by crosslinking
was at least twice the [Ca21]i of the basal level. In this sense,
anti-CD3 induced a rapid and significant (within 1 minute)
[Ca21]i increase in 65% of cells, with these cells exhibiting a
mean peak [Ca21]i of 414 6 10 nmol/L. This was followed by
smaller [Ca21]i oscillations, especially in those cells with a
higher [Ca21]i peak (polytopic response). The asynchronous
[Ca21]i oscillations observed at the single cell level are respon-
sible for the sustained phase of the [Ca21]i changes identified in
cell suspension experiments. The reduction in the mean [Ca21]i
response observed after CD31CD45 cocrosslinking was basi-
cally caused by a decrease in the immediate Ca21 mobilization,
affecting an average of 69% of the responding cells. As may
also be observed in Fig 8, crosslinking of CD45 alone did not
induce any significant modification of the [Ca21]i levels. With
respect to the inhibitory effect of CD148 on CD3-induced
Fig 5. Immunofluorescence analysis of mock-transfected COS-7
cells (A) or COS-7 cells transfected with HPTP-h cDNA (B). COS-7 cells
were transfected with hp21 clone encoding HPTP-h or plasmid only
and stained with 143-41–FITC as described in the Materials and
Methods.
Fig 6. PTP activity of purified CD148 molecule. Affinity purified
CD148 molecule was incubated with a tyrosine phosphorylated
syntethic peptide (TSTEPQpYQPGENL). The amount of free phos-
phate released as inorganic phosphate in the absence or presence of
vanadate was measured by the Malachite Green Phosphatase Assay
(UBI) and it is shown as nmol/L concentration. Affinity purified CD50
molecule was used as a negative control.
2804 DE LA FUENTE-GARCI´A ET AL
 For personal use only. at Harvard Libraries on August 27, 2013. bloodjournal.hematologylibrary.orgFrom 
stimulation, we observed a decrease in the immediate response
in 35% of the cells.
Individual responses to CD148 crosslinking exhibited a
synchronized, more than twofold increase in [Ca21]i in 39% of
the cells (Fig 8). This increase, which was delayed (1 minute) if
it was compared with the rapid response observed after CD3
crosslinking, was significantly different from the levels ob-
served in the presence of an isotype matched control MoAb
(111-5A1, CD41; data not shown). Likewise, no response was
observed after adding GAM to the sample. The inhibitory effect
of CD45 cocrosslinking was observed to affect 80% of CD148
responding cells, affecting especially the early phase of the
response (Fig 8). These data suggest that the crosslinking of
CD148 could induce Ca21 mobilization through tyrosine phos-
phorylation processes. To better characterize this point, the
response to CD148 crosslinking in the presence of a known
protein tyrosine kinase inhibitor, genistein, was analyzed. The
data presented in Fig 9A show that genistein clearly inhibits the
Ca21 mobilization induced by CD148 croslinking. When indi-
vidual cell measurements of the [Ca21]i changes were analyzed
after CD148 crosslinking in the absence (Fig 9B) or presence of
genistein 75 µmol/L (Fig 9C) it was confirmed that the
inhibition observed in the presence of genistein was real and not
caused by the induction of unsynchronized responses. The
inhibitory effect of genistein affected 70% of CD148 respond-
ing cells, mainly during the early phase of the response
(Fig 9C).
Induction of tyrosine phosphorylation by CD148 crosslink-
ing. The results of the CD45 cocrosslinking and genistein
experiments led us to investigate whether specific tyrosine
phosphorylation events were associated with anti-CD148–
triggered Ca21 mobilization. Thus, cells previously coated with
CD3, CD148, or both were lysed in SDS sample buffer at
various times after addition of rabbit antimouse antiserum and
tyrosine-phosphorylated proteins were detected by immunoblot-
ting. As shown in Fig 10, and as it has been exhaustively
described, a rapid increase in the phosphotyrosine content of
several proteins was observed after CD3 crosslinking (Fig 10A,
lanes 2 and 3). In addition, phosphorylation of several sub-
strates after CD148 crosslinking was also evident (Fig 10A,
Fig 7. Calcium mobilization induced after CD3, CD148, and
CD31CD148 crosslinking. Peripheral blood lymphocytes were loaded
with fura-2, and [Ca21]i was measured as described in the Materials
and Methods. Cells were incubated 30 minutes at 4°C with the
different MoAbs (CD3, 10 mg/mL; 143-41, 50 mg/mL; CD45, 50 mg/mL)
and adhered to Cell-Tak coated coverslips. After establishing baseline
values, a saturating amount of GAM was added to prewarmed
samples (arrow). [Ca21]i was measured every 5 seconds for 15
minutes on a single-cell basis in a computer-aided fluorescence
imaging. The average curve of a minimum of 200 individual cells for
each condition of at least four independent experiments are shown.
Calcium changes are expressed as the percentage change from basal.
Fig 8. Fluorescence imaging of [Ca21]i responses from individual
cells after CD3, CD148, and CD31CD148 crosslinking. Cells previously
loaded with fura-2 (2 mmol/L), were incubated with the correspond-
ing antibody (CD3, 10 mg/mL; 14341, 40 mg/mL; CD45, 40 mg/mL) for
30 minutes at 4°C. After washing, cells were plated on Cell-Tak–
coated glass coverslips. After establishing baseline values, saturating
amount of polyclonal GAM was added to prewarmed samples. [Ca21]i
was measured every 5 seconds for 15 minutes in every cell. Calcium
changes are expressed as the percentile change of basal. A total of 20
cells representative of each condition are shown. Each line represents
an individual cell.
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lanes 4 and 5). These results are in agreement with those that
have been presented previously and suggest that the Ca21
mobilization induced by CD148 crosslinking could be mediated
by tyrosine phosphorylation events.
On the other hand, and taking into account the tyrosine
phosphatase activity of CD148, we were interested to know
whether the CD148-induced inhibition of CD3-mediated Ca21
mobilization was caused by specific dephosphorylation event(s).
The pattern of protein tyrosine phosphorylation after activation
of human lymphocytes with CD3 crosslinking was modified
when CD148 was cocrosslinked to this receptor (Fig 10A, lanes
6 and 7). Thus, a selective inhibition of some substrate was
detected, which could be related with the phosphatase activity
of CD148. Taking into account the previously established
relationship between calcium mobilization and tyrosine phos-
phorylation of phospholipase C g (PLC-g) we were interested
in analyzing the phosphorylation status of this enzyme after cell
stimulation. Cells coated with CD3, CD148, or both were
stimulated with rabbit antimouse Ig and after cell lysis at
different times, PLC-g was immunoprecipitated. The immuno-
blotting with an antiphosphotyrosine antibody (Fig 10B) showed
that, whereas after stimulating with CD3 and CD148 an
increase in tyrosine phosphorylation of PLC-g was observed, a
clear decrease was detected when both CD3 and CD148 were
cocrosslinked. By reprobing with an anti–PLC-g it was ob-
served that the same quantity of PLC-g was loaded on each
lane. These results are in agreement with the data provided by
Ca21 mobilization analysis.
In addition, it was observed that cotriggering of CD3 with
CD148 resulted in an increase in protein tyrosine phosphoryla-
tion in some other proteins. This increase in the phosphorylation
pattern was particularly evident on a 56-kD substrate.
DISCUSSION
During recent years there has been an increase in the
description of new PTPs,3 although the majority of these PTPs
have been mainly related to activities of the central nervous
system. In contrast, although the number of PTKs involved in
lymphocyte signal transduction has also grown, this has not
been the case for the number of PTPs involved in this process.
In addition to the cytoplasmic PTPs involved in lymphocyte
signaling, just one membrane PTP, CD45, is known to influence
the signaling process after antigen receptor engagement (see
Streuli21 for review). In this paper, we have presented evidences
showing that in addition to CD45, there is another PTP on the
Fig 9. Effect of Genistein on calcium mobilization induced by
CD148 crosslinking. Peripheral blood lymphocytes were loaded with
fura-2, and [Ca21]i was measured as described in the Materials and
Methods. Cells were incubated 30 minutes at 4°C with 50 mg/mL of
CD148 and adhered to Cell-Tak–coated coverslips. After establishing
baseline values, a saturating amount of GAM was added in the
absence or presence 0f 75 mmol/L Genistein to prewarmed samples
(arrow). [Ca21]i was measured every 5 seconds for 15 minutes on a
single-cell basis in a computer-aided fluorescence imaging. (A) The
average curve of a minimum of 200 individual cells for each condition
of at least four independent experiments are shown. Calcium changes
are expressed as the percentage change from basal. Fluorescence
imaging of [Ca21]i responses from 20 individual cells, after CD148
crosslinking, in the absence (B) or the presence (C) of genistein (75
mmol/L). Each line represents an individual cell.
Fig 10. Protein tyrosine phosphorylation induced by CD148
crosslinking. (A) Cells were incubated without (lane 1) or with (lanes 2
to 7) 10 mg of the different monoclonal antibodies for 15 minutes at
4°C followed by the addition of crosslinking rabbit antimouse Igs.
Incubation was terminated after 1 minute (lanes 2, 4, and 6) and 5
minutes (lanes 3, 5, and 7). Proteins were resolved by SDS-PAGE
followed by antiphosphotyrosine immunoblotting. (B) PLC-g1 was
immunoprecipitated from cells stimulated during 1 and 3 minutes
and analyzed by Western blot with an antiphosphotyrosine antibody
and, after stripping, with an anti–PLC-g1.
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lymphocyte membrane that could be able to modulate the
signaling process after CD3 crosslinking. Thus, we have
observed that the cocrosslinking of the molecule recognized by
the MoAb 143-41, together with CD3 inhibits the subsequent
[Ca21]i increase. Our results show that this molecule is a
membrane protein tyrosine phosphatase identical to a recently
described HPTP called HPTP-h12 or DEP-1.13 This phosphatase
is present on the membrane of all the hematopoietic cells and it
has been classified as CD148 during the last VI WLDA.10
Within the lymphoid cells, it is preferentially expressed on B
cells, memory T lymphocytes, and mature thymocytes (A.
Gaya´, unpublished observations). In contrast, its expression on
hematopoietic cell lines is heterogeneous. Thus, whereas it is
clearly expressed on myeloid cell lines and on the majority of
B-cell lines tested it is absent from the majority of T-cell lines
analyzed. Although this pattern of distribution could seem
contradictory there are other molecules that display a similar
pattern of distribution. Thus, CD26, which is clearly present on
all mature T lymphocytes is absent from T-cell lines with the
exception of HSB-2.22
We have presented several pieces of evidence showing that
CD148 is identical to HPTP-h12 and DEP-1.13 First, the
sequences we obtained by protein sequencing and the previ-
ously published cDNA sequences of HPTP-h12 and DEP-113 are
identical. These sequences include an N-terminal fragment of
18 amino acids as well as two different CNBr-derived peptides
of 18 aa. We consider those sequences as identical at all of the
resolved positions, and the nonresolved positions can be
explained by technical problems inherent in the sequencing
process. The most interesting aspect of these data is the
determination that the N-terminal residue of the mature protein
corresponds to an Ala and not to the previously proposed Thr12
or Gly.13 Second, when COS-7 cells were transfected with a
plasmid (hp21) containing a HPTP-h encoding cDNA clone,12 a
clear reaction with 143-41 MoAb was observed. Third, by using
an immunopurified preparation of CD148 molecule, obtained
from leukocyte membranes, it was possible to determine its
capacity to release free phosphate groups from a tyrosine
phosphorylated peptide, thus, confirming its tyrosine phospha-
tase activity. The immunochemical characterization of CD148
molecule confirmed that this molecule contains both O- and
N-linked carbohydrates. From the analysis with glycosidases it
could be deduced that the major part of carbohydrates are
N-linked. This is in agreement with the 34 potential sites for
N-linked glycosilation determined from the cDNA sequence10,11
and the data presented by Honda et al12 on N-glycosidase F
treatment of HPTP-h. Concerning the apparent molecular
weight of HPTP-h, differences have been described among
several cell lines11,12 varying from 250 kD (HL60) to 230 kD
(F-36P) or 220 kD (F-36E). Taking into account that CD148
molecule was obtained from a heterogeneous population of
cells, the broad band around 240 kD we have observed both by
immunoprecipitation and immunoafinity purification could in-
clude all the forms previously mentioned, suggesting the
existence of a certain level of heterogeneity in the expression of
this phosphatase among several cellular lineages.
HPTP-h or DEP-1 is a recently described receptor PTP, the
extracellular portion of which is composed of 813 or 1012 FNIII
domains, whereas the intracellular segment contains a single
PTP domain spanning amino acids 1060 to 1296. Therefore, it
joins an expanding group of such receptors classified as type III
PTPs3 that includes PTP-b,23 PTP-U2,24 GLEPP1,25 and SAP-
126 from humans and DPTP10D,27 DPTP99A,28 and DPTP4E29
from Drosophila, with HPTP-h being the unique type III PTP
expressed on hematopoietic cells. These enzymes are character-
ized by a similar organization of their extracellular segments,
which consist of a repeated array of FNIII motifs, and a single
intracytoplasmic phosphatase domain. The FNIII repeats, in
addition to being involved in adhesion processes,29 are also
found in the extracellular regions of the receptors for interleu-
kin-2 (IL-2), IL-4, IL-6, granulocyte-macrophage colony-
stimulating factor, prolactin, erythropoietin, and growth hor-
mone.30 The DEP-1 molecule has been implicated in contact
inhibition of cell growth because it is upregulated in dense cell
cultures although its upregulation is initiated before saturation
density is reached. In addition, it has been described that the
expression level of HPTP-h was altered when the HL-60 cells
were exposed to differentiating compounds such as dimethyl
sulfoxide and 12-O-tetra decanoyl phorbol 13-acetate, suggest-
ing that this gene might be involved in the differentiating
processes for granulocyte or monocyte/macrophage lineages in
these cells.11
The CD45 molecule, the principal protein tyrosine phospha-
tase present on the membrane of hematopoietic cells, is capable
of regulating signal transduction and functional responses,7-9
because in T lymphocytes, CD45 crosslinking inhibits inositol
phosphate production, calcium flux, and proliferation.31 The
ability of CD45 to modulate signals transduced by CD3
correlates with its ability to inhibit the tyrosine phosphorylation
of some intracellular protein substrates.31,32 Once we showed
that the molecule recognized by the 143-41 MoAb is a
membrane protein tyrosine phosphatase, we were interested to
know whether this molecule could influence the signal transduc-
tion through the antigen receptor. The most striking fact of this
analysis was the observation that the crosslinking of CD148
alone was able to induce a clear increase in [Ca21]i. This
phenomenon was not observed after CD45 crosslinking. The
kinetic of the process was similar to the Ca21 mobilization
induced after CD3 crosslinking, although the lag time was
clearly more prolonged in the case of CD148. Another differ-
ence was based on the intensity of the response. The CD148
crosslinking produced both a lower level of [Ca21]i mobiliza-
tion and a lower number of responding cells (39% v 69%). In
fact, CD148 crosslinking was able to decrease the Ca21
mobilization in 35% of the cells responding to CD3 (69%), a
percentage similar to the percentage of cells responding to
CD148 crosslinking (39%).
Concerning the mechanisms involved in this process, we
consider it plausible that tyrosine phosphorylation could be
involved because the cocrosslinking with CD45 or the presence
of genistein were able to abolish the response induced by
CD148. This assumption was proven to be correct, because after
CD148 crosslinking a clear pattern of tyrosine phosphorylation
could be observed. Especially interesting was the observation
that CD148 crosslinking was able to induce tyrosine phosphory-
lation of PLC-g1. Although it may seem contradictory that a
protein tyrosine phosphatase is able to induce tyrosine phosphor-
ylation, a similar situation has been described for the molecule
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CD45.33-35 In this case, the association of p56lck with the
cytoplasmic tail of CD4535,36 results in an increase in the
catalytic activity of the PTK after CD45 crosslinking.37 In a
similar way, the existence of an association of CD148 with
some PTK able to mediate the observed increase in Ca21, could
be considered. This PTK could be activated through dephos-
phorylation by the tyrosine phosphatase domain of CD148,
similar to the way in which CD45 dephosphorylates Y505 on
p56lck, turning the inactive protein into an active PTK.38
In addition, we have also observed that CD148 was able to
inhibit the Ca21 mobilization induced by CD3 MoAb when both
molecules were cocrosslinked. This could have occurred by
bringing the PTP domain of CD148 into close proximity with
the cytoplasmic domain of a signaling molecule. In this way its
activity could be triggered by changing the phosphorylation
status of critical tyrosine residues used in signal transduction, as
has been described with CD45.31,32 Although Shivnan et al39
have suggested that some of the results of coclustering experi-
ments with CD45 may have to do with interfering with CD3
clustering, we have observed no interference in our experi-
mental model when CD3 was cocrosslinked with lymphocyte
function-associated antigen (data not shown), thus discarding
an unspecific effect. However, whether the inhibition of CD148
on CD3 signaling is based on the phosphorylation or the
dephosphorylation of some substrate(s) remains to be deter-
mined. In spite of the tyrosine phosphatase activity of CD148
no general dephosphorylation was observed after CD3 and
CD148 cocrosslinking. In fact, only a very selective inhibition
of a few substrates was detected, the most significant being the
dephosphorylation of PLC-g. This dephosphorylation could
account for the inhibition of Ca21 mobilization, in a way similar
to CD45.31,32 In this case also few very selective dephosphoryla-
tion events have been related by CD3 signaling inhibition.33,34 It
could seem contradictory that the cocrosslinking of CD148 and
CD3 results in no signal whereas engagement of either mol-
ecule by itself causes significant signal transduction events to
occur. Although we have no definitive data to explain these facts, a
possible explanation could be that the kinase activity activated
through CD148 crosslinking would be modified after cocrosslink-
ing CD148 with CD3, whereas the own phosphatase activity of
CD148 would remain intact. If this were the case, the activation
of PLC-g by CD3 would be decreased by the phosphatase
activity of CD148 and it would not be compensated by the
activation through CD148. The net result of this process would
be a diminished activation of PLC-g and consequently the
inhibition of Ca21 mobilization. On the other hand, our results
also show an increase in the phosphorylation of some substrates
after CD3 and CD148 cocrosslinking. This fact was particularly
evident in a 56-kD substrate. Corvaı¨a et al40 have also described
an increase in protein tyrosine phosphorylation of some sub-
strates after cotriggering human monocytes with FcgRI or
FcgRII with CD45. Thus, the possibility that a specific phosphor-
ylation of some substrate could be responsible for the inhibition
of the signaling process through CD3 could not be ruled out.
In conclusion, in the present report we have shown a
functional role for a recently described membrane protein
tyrosine phosphatase, which is involved in the signaling path-
ways of T lymphocytes, opening a new avenue of research into
the signal transduction pathways of these cells.
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